🔎 Trials Near Me

Akèy › Kansè Ezofajyen › Florid › Orlando

Etid klinik pou Kansè Ezofajyen nan Orlando, FL

8 etid pou Kansè Ezofajyen ap chèche patisipan nan sit nan ak bò kote Orlando (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

Ap rekriteFaz 2
  • AdventHealth Medical Group Oncology Research at Celebration, Kissimmee · 16 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT06172478

Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors

Ap rekriteFaz 1
  • Sara Cannon Research Institute Lake Nona, Orlando
Laj 18 ak plis · Tout sèks · Mizajou Sep 21, 2026 · NCT05983432

Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors

Ap rekriteFaz 1
  • Sarah Cannon Research Institute - Lake Nona Florida, Orlando
Laj 18 ak plis · Tout sèks · Mizajou Sep 10, 2026 · NCT06293898

A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

Ap rekriteFaz 1/2
  • AdventHealth Celebration, Celebration · 17 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Aug 11, 2026 · NCT05592626

A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors

Ap rekriteFaz 1/2
  • Sarah Cannon Research Institute (Lake Nona), Orlando
Laj 18 ak plis · Tout sèks · Mizajou Jul 29, 2026 · NCT03526835

A Study of Sigvotatug Vedotin in Advanced Solid Tumors

Ap rekriteFaz 1
  • Florida Cancer Specialists, Orlando
Laj 18 ak plis · Tout sèks · Mizajou Jul 6, 2026 · NCT04389632

A Study to Evaluate the Safety, Pharmacokinetics and Efficacy of TJ101 in Patients With Advanced/Metastatic Solid Tumors

Ap rekriteFaz 1
  • Florida Cancer Specialists & Research Institute, Orlando
Laj 18 ak plis · Tout sèks · Mizajou Jan 12, 2026 · NCT07181473

Etid Kansè Ezofajyen nan lòt vil

Lòt etid nan Orlando

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.